20/20 Biolabs, Inc.

20/20 Biolabs, Inc. is a commercial-stage diagnostics company focused on AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases. The company’s core offerings include the OneTest family, which covers multi-cancer early detection testing and longevity-related biomarker analysis. It also operates CLIAx, a clinical laboratory innovation platform that supports diagnostic development and testing workflows for emerging health technology companies. 20/20 Biolabs serves the healthcare diagnostics market with products and services designed to improve clinical utility through machine learning and real-world data. Based in Gaithersburg, Maryland, the company plays a role in expanding access to advanced laboratory testing and supporting broader adoption of precision diagnostics.